AAAAAA

   
Results: 1-18 |
Results: 18

Authors: LISTON TE CONKLYN MJ HOUSER J WILNER KD JOHNSON A APSELOFF G WHITACRE C SHOWELL HJ
Citation: Te. Liston et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF THE LEUKOTRIENE B-4 RECEPTORANTAGONIST CP-105,696 IN MAN FOLLOWING SINGLE ORAL-ADMINISTRATION, British journal of clinical pharmacology, 45(2), 1998, pp. 115-121

Authors: HAMELIN BA ALLARD S LAPLANTE L MICELI J WILNER KD TREMBLAY J LEBEL M
Citation: Ba. Hamelin et al., THE EFFECT OF TIMING OF A STANDARD MEAL ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NOVEL ATYPICAL ANTIPSYCHOTIC AGENT ZIPRASIDONE, Pharmacotherapy, 18(1), 1998, pp. 9-15

Authors: GOFF DC POSEVER T HERZ L SIMMONS J KLETTI N LAPIERRE K WILNER KD LAW CG KO GN
Citation: Dc. Goff et al., AN EXPLORATORY HALOPERIDOL-CONTROLLED DOSE-FINDING STUDY OF ZIPRASIDONE IN HOSPITALIZED-PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER, Journal of clinical psychopharmacology, 18(4), 1998, pp. 296-304

Authors: RONFELD RA TREMAINE LM WILNER KD
Citation: Ra. Ronfeld et al., PHARMACOKINETICS OF SERTRALINE AND ITS N-DEMETHYL METABOLITE IN ELDERLY AND YOUNG MALE AND FEMALE VOLUNTEERS, Clinical pharmacokinetics, 32, 1997, pp. 22-30

Authors: TREMAINE LM WILNER KD PRESKORN SH
Citation: Lm. Tremaine et al., A STUDY OF THE POTENTIAL EFFECT OF SERTRALINE ON THE PHARMACOKINETICSAND PROTEIN-BINDING OF TOLBUTAMIDE, Clinical pharmacokinetics, 32, 1997, pp. 31-36

Authors: APSELOFF G WILNER KD GERBER N TREMAINE LM
Citation: G. Apseloff et al., EFFECT OF SERTRALINE ON PROTEIN-BINDING OF WARFARIN, Clinical pharmacokinetics, 32, 1997, pp. 37-42

Authors: GARDNER MJ BARIS BA WILNER KD PRESKORN SH
Citation: Mj. Gardner et al., EFFECT OF SERTRALINE ON THE PHARMACOKINETICS AND PROTEIN-BINDING OF DIAZEPAM IN HEALTHY-VOLUNTEERS, Clinical pharmacokinetics, 32, 1997, pp. 43-49

Authors: RONFELD RA WILNER KD BARIS BA
Citation: Ra. Ronfeld et al., SERTRALINE - CHRONOPHARMACOKINETICS AND THE EFFECT OF COADMINISTRATION WITH FOOD, Clinical pharmacokinetics, 32, 1997, pp. 50-55

Authors: ZIEGLER MG WILNER KD
Citation: Mg. Ziegler et Kd. Wilner, SERTRALINE DOES NOT ALTER THE BETA-ADRENERGIC BLOCKING ACTIVITY OF ATENOLOL IN HEALTHY MALE-VOLUNTEERS, The Journal of clinical psychiatry, 57, 1996, pp. 12-15

Authors: WILNER KD JOHNSON AC MICELI JJ FRICKE JR TITUS CK
Citation: Kd. Wilner et al., ANXIOLYTIC EFFECTS OF ZIPRASIDONE, AN ATYPICAL ANTIPSYCHOTIC, COMPARED WITH DIAZEPAM AND PLACEBO ON SUBJECTS PRIOR TO UNDERGOING MINOR DENTAL SURGERY, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 73-73

Authors: BERL T WILNER KD GARDNER M HANSEN RA FARMER B BARIS BA HENRICH WL
Citation: T. Berl et al., PHARMACOKINETICS OF FLUCONAZOLE IN RENAL-FAILURE, Journal of the American Society of Nephrology, 6(2), 1995, pp. 242-247

Authors: GARDNER MJ WILNER KD HANSEN RA FOUDA HG MCMAHON GF
Citation: Mj. Gardner et al., SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF TENIDAP SODIUM IN HEALTHY-SUBJECTS, British journal of clinical pharmacology, 39, 1995, pp. 11-15

Authors: WILNER KD GARDNER MJ
Citation: Kd. Wilner et Mj. Gardner, CIMETIDINE DOES NOT ALTER THE CLEARANCE OR PLASMA-BINDING OF TENIDAP IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 39, 1995, pp. 21-24

Authors: APSELOFF G WILNER KD VONDEUTSCH DA GERBER N
Citation: G. Apseloff et al., TENIDAP SODIUM DECREASES RENAL CLEARANCE AND INCREASES STEADY-STATE CONCENTRATIONS OF LITHIUM IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 39, 1995, pp. 25-28

Authors: APSELOFF G WILNER KD GERBER N
Citation: G. Apseloff et al., EFFECT OF TENIDAP SODIUM ON THE PHARMACODYNAMICS AND PLASMA-PROTEIN BINDING OF WARFARIN IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 39, 1995, pp. 29-33

Authors: BLUM RA SCHENTAG JJ GARDNER MJ WILNER KD
Citation: Ra. Blum et al., THE EFFECT OF TENIDAP SODIUM ON THE DISPOSITION AND PLASMA-PROTEIN BINDING OF PHENYTOIN IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 39, 1995, pp. 35-38

Authors: WILNER KD GARDNER MJ
Citation: Kd. Wilner et Mj. Gardner, TENIDAP SODIUM DOES NOT ALTER THE CLEARANCE OR PLASMA-PROTEIN BINDINGOF TOLBUTAMIDE IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 39, 1995, pp. 39-42

Authors: MICELI JJ HUNT T COLE MJ WILNER KD
Citation: Jj. Miceli et al., THE PHARMACOKINETICS (PK) OF CP-88,059 (CP) IN HEALTHY MALE-VOLUNTEERS FOLLOWING ORAL (PO) AND INTRAVENOUS (IV) ADMINISTRATION, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 142-142
Risultati: 1-18 |